Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M HORWITZ

Showing results (261-270 of 830) with videos related to

Pageof 83
Sort By:
Pediatric Blood & Cancer|January 20, 2006
EBV lymphoproliferative disease of host origin after haploidentical stem cell transplantationKimberly A Kasow, Wing Leung, Edwin M Horwitz, et al.
International Journal of Radiation Oncology, Biology, Physics|May 23, 2002
Biochemical failure rates in prostate cancer patients predicted to have biologically insignificant tumors treated with three-dimensional conformal radiation therapyNoel M Kramer, Alexandra L Hanlon, Eric M Horwitz, et al.
Gene Therapy|April 9, 2005
Correction of a mineralization defect by overexpression of a wild-type cDNA for COL1A1 in marrow stromal cells (MSCs) from a patient with osteogenesis imperfecta: a strategy for rescuing mutations that produce dominant-negative protein defectsR R Pochampally, E M Horwitz, C M DiGirolamo, et al.
Journal of the American Academy of Dermatology|November 15, 2017
Unrelated immunodeficiency states may impact outcomes and immune checkpoint molecule expression in patients with mycosis fungoides: A clinicopathologic case-control studyShay Warren, Meenal Kheterpal, Patricia L Myskowski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2000
The role of a mitochondrial pathway in the induction of apoptosis by chemicals extracted from diesel exhaust particlesT S Hiura, N Li, R Kaplan, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2002
Advantages of using noncoplanar vs. axial beam arrangements when treating prostate cancer with intensity-modulated radiation therapy and the step-and-shoot delivery methodRobert A Price, Gerald E Hanks, Shawn W McNeeley, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2003
Biochemical failure as a determinant of distant metastasis and death in prostate cancer treated with radiotherapyAlan Pollack, Alexandra L Hanlon, Benjamin Movsas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 25, 2010
Guidance for developing phase II cell therapy trial proposals for consideration by the Blood and Marrow Transplant Clinical Trials NetworkEdwin M Horwitz, Mary M Horowitz, Nancy L DiFronzo, et al.
Cancer|February 6, 2003
Validation of a treatment policy for patients with prostate specific antigen failure after three-dimensional conformal prostate radiation therapyWayne H Pinover, Eric M Horwitz, Alexandra L Hanlon, et al.
World Journal of Urology|September 10, 2003
Radiation therapy dose escalation for prostate cancer: a rationale for IMRTAlan Pollack, Alex Hanlon, Eric M Horwitz, et al.
Pageof 83

Showing results (261-270 of 830) with videos related to

Sort By:
Pageof 83
Pediatric Blood & Cancer|January 20, 2006
EBV lymphoproliferative disease of host origin after haploidentical stem cell transplantationKimberly A Kasow, Wing Leung, Edwin M Horwitz, et al.
International Journal of Radiation Oncology, Biology, Physics|May 23, 2002
Biochemical failure rates in prostate cancer patients predicted to have biologically insignificant tumors treated with three-dimensional conformal radiation therapyNoel M Kramer, Alexandra L Hanlon, Eric M Horwitz, et al.
Gene Therapy|April 9, 2005
Correction of a mineralization defect by overexpression of a wild-type cDNA for COL1A1 in marrow stromal cells (MSCs) from a patient with osteogenesis imperfecta: a strategy for rescuing mutations that produce dominant-negative protein defectsR R Pochampally, E M Horwitz, C M DiGirolamo, et al.
Journal of the American Academy of Dermatology|November 15, 2017
Unrelated immunodeficiency states may impact outcomes and immune checkpoint molecule expression in patients with mycosis fungoides: A clinicopathologic case-control studyShay Warren, Meenal Kheterpal, Patricia L Myskowski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2000
The role of a mitochondrial pathway in the induction of apoptosis by chemicals extracted from diesel exhaust particlesT S Hiura, N Li, R Kaplan, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2002
Advantages of using noncoplanar vs. axial beam arrangements when treating prostate cancer with intensity-modulated radiation therapy and the step-and-shoot delivery methodRobert A Price, Gerald E Hanks, Shawn W McNeeley, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2003
Biochemical failure as a determinant of distant metastasis and death in prostate cancer treated with radiotherapyAlan Pollack, Alexandra L Hanlon, Benjamin Movsas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 25, 2010
Guidance for developing phase II cell therapy trial proposals for consideration by the Blood and Marrow Transplant Clinical Trials NetworkEdwin M Horwitz, Mary M Horowitz, Nancy L DiFronzo, et al.
Cancer|February 6, 2003
Validation of a treatment policy for patients with prostate specific antigen failure after three-dimensional conformal prostate radiation therapyWayne H Pinover, Eric M Horwitz, Alexandra L Hanlon, et al.
World Journal of Urology|September 10, 2003
Radiation therapy dose escalation for prostate cancer: a rationale for IMRTAlan Pollack, Alex Hanlon, Eric M Horwitz, et al.
Pageof 83